Accelerant Reports Q3 2026 Results, $71.3 Million Adjusted EBITDA
Accelerant reported Q3 2026 revenue of $278.6M, a net loss of $9.2M, and adjusted EBITDA of $71.3M. Exchange Written Premium grew 27% YoY to $1.33B. The company expects its Thoma Bravo transaction to close in H1 2027. Accelerant had 340 members at quarter-end, up from 265 YoY, and added 26 MGAs during the quarter. The company will not host an earnings call or provide guidance while the transaction is pending.
How this was made
The 30-second read
Why it matters
The Q3 earnings reveal a net loss despite revenue growth, highlighting short‑term profitability concerns while the pending transaction remains a key catalyst.
Market read
Earnings miss and pending M&A create mixed short‑term risk, but the acquisition could drive longer‑term upside.
What to watch
Strong exchange written premium growth and high net revenue retention suggest underlying business strength.
Background
Accelerant Holdings (ARX) is a specialty insurance platform that recently announced a pending acquisition by private equity firm Thoma Bravo.
Ticker impact
Accelerant reported Q3 2026 results with adjusted EBITDA of $71.3M and reiterated pending Thoma Bravo transaction closing in H1 2027.
likely pressure as investors digest the net loss and pending deal uncertainty
The disclosed loss and lack of guidance increase downside risk; the acquisition remains a catalyst but is uncertain.
Market effects
Insurance and reinsurance sector may see heightened scrutiny on loss ratios and acquisition activity.
U.S. market participants may adjust exposure to specialty insurers.
Limited to firms tracking M&A activity in the insurance space.
Counterpoint
If the Thoma Bravo deal closes, the premium could offset the earnings weakness.
Key entities
- companyAccelerant Holdings
Specialty insurance platform reporting Q3 2026 results.
- private equityThoma Bravo
Potential acquirer of Accelerant, deal expected to close H1 2027.